Endothelium-dependent relaxation factor released by perivascular adipose tissue

Journal of Hypertension

Volumn 27, Issue 4, 2009, Pages 782-790

  Lee, Robert M K W ^a   Lu, Chao ^a   Su, Li Ying ^a   Gao, Yu Jing ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adipose tissue; Angiotensin 1 7; Aorta; Nitric oxide; Relaxation

Indexed keywords

ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CALCIUM ACTIVATED POTASSIUM CHANNEL BLOCKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DX 600; ENALAPRILAT; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT;

EID: 67649663972     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328324ed86     Document Type: Article

References (45)

1. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J 2002; 16:1057-1063.
2. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol 2004; 286:H1107-H1113.
3. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension 2004; 44:271-276.
4. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, et al. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 2005; 130:1130-1136.
5. Gao YJ, Lu C, Su LY, Sharma AM, Lee RMKW. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 2007; 151:323-331.
6. Takemori K, Gao YJ, Ding L, Lu C, Su LY, An WS, et al. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 2007; 49:365-372.
7. Gao YJ, Holloway AC, Zeng ZH, Lim GE, Petrik JJ, Foster WG, et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 2005; 13:687-692.
8. Gao YJ, Holloway AC, Su LY, Takemori K, Lu C, Lee RM. Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life. Eur J Pharmacol 2008; 590:264-268.
9. Lee RM, Lu C, Su LY, Werstuck GH, Gao YJ. Effects of hyperglycemia on the modulation of vascular function by perivascular adipose tissue. J Hypertens 2009; 27:118-131.
10. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, et al. Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 2006; 71:363-373.
11. Lu C, Su LY, Lee RM, Gao YJ. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation. Eur J Pharmacol 2008; 589:188-193.
12. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60:329-339.
13. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 1993; 22:513-522.
14. Campbell DJ, Duncan A-M, Kladis A, Harrap SB, Duncan AM. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1995; 26:426-436.
15. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 1994; 15:919-926.
16. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension 1995; 25 (4 Pt 2):796-802.
17. Yagil Y, Yagil C. Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 2003; 41:871-873.
18. Santos RA, Brosnihan KB, Chappell MC, Pesquero J, Chernicky CL, Greene LJ, et al. Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension 1988; 11 (2 Pt 2):I153-I157.
19. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin(1-7). Peptides 1993; 14:679-684.
20. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995; 269 (1 Pt 2):H313-H319.
21. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005; 289:H2281-H2290.
22. Reudelhuber TL. A place in our hearts for the lowly angiotensin 1-7 peptide? Hypertension 2006; 47:811-815.
23. Ferrario CM, Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 2004; 61:2720-2727.
24. Campbell DJ, Duncan A-M, Kladis A, Harrap SB. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 1995; 25:928-934.
25. Galvez-Prieto B, Bolbrinker J, Stucchi P, Las Heras AI, Merino B, Arribas S, et al. Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 2008; 197:55-64.
26. Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 2003; 35: 807-825.
27. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM. Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J Cardiovasc Pharmacol 2005; 45:136-143.
28. Gauthier KM, Zhang DX, Edwards EM, Holmes B, Campbell WB. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocrinology 2005; 146:3319-3324.
29. Gauthier KM, Zhang DX, Cui L, Nithipatikom K, Campbell WB. Angiotensin II relaxations of bovine adrenal cortical arteries. role of angiotensin II metabolites and endothelial nitric oxide. Hypertension 2008; 52:150-155.
30. Yamaguchi K, Nishimura H. Angiotensin II-induced relaxation of fowl aorta. Am J Physiol 1988; 255 (4 Pt 2):R591-R599.
31. Hannan RE, Davis EA, Widdop RE. Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol 2003; 140:987-995.
32. Soares DM, Resende AC, Emiliano AF, Tano T, Mendes-Ribeiro AC, Correia ML, et al. The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol 2004; 141:860-866.
33. Tirapelli CR, Fukada SY, de Godoy MA, de Oliveira AM. Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sci 2006; 78:2676-2682.
34. Grbovic L, Djokic J, Radenkovic M, Pesic S. Analysis of the vasorelaxant action of angiotensin II in the isolated rat renal artery. J Pharmacol Sci 2008; 106:376-384.
35. Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, et al. Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab 2004; 89:965-970.
36. Miki I, Seya K, Motomura S, Furukawa K. Role of corticotropin-releasing factor receptor type 2 beta in urocortin-induced vasodilation of rat aortas. J Pharmacol Sci 2004; 96:170-176.
37. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Where are we now? Arterioscler Thromb Vasc Biol 2006; 26:1215-1225.
38. Cases A. Omapatrilat: clinical pharmacology. Drugs Today (Barc) 2000; 36:817-828.
39. Ferro CJ, Spratt JC, Haynes WG, Webb DJ. Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo. Circulation 1998; 97:2323-2330.
40. Gao XP, Rubinstein I. Neutral endopeptidase modulates substance P-induced vasodilation in vivo. J Appl Physiol 1995; 78:562-568.
41. Ferrario CM, Smith RD, Brosnihan B, Chappell MC, Campese VM, Vesterqvist O, et al. Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension. Am J Hypertens 2002; 15:557-564.
42. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 2009 [Epub ahead of print].
43. Yang L, Gao YJ, Lee RMKW. Quinapril effects on resistance artery structure and function in hypertension. Naunyn Schmiedebergs Arch Pharmacol 2004; 370:444-451.
44. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998; 31:699-705.
45. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28:104-108.